{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:37:03Z","timestamp":1790397423498,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s40290-022-00447-7","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T17:02:50Z","timestamp":1668099770000},"page":"387-400","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The Characteristics of Clinical Trials on Cannabis and Cannabinoids: A Review of Trials for Therapeutic or Drug Development Purposes"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8863-7193","authenticated-orcid":false,"given":"Farhang","family":"Modaresi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2772-6800","authenticated-orcid":false,"given":"Kaivan","family":"Talachian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"issue":"3","key":"447_CR1","first-page":"180","volume":"42","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman MB, Abazia DT. Medicinal cannabis: history, pharmacology, and implications for the acute care setting. Pharm Ther. 2017;42(3):180\u20138.","journal-title":"P T"},{"issue":"1\u20132","key":"447_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","volume":"105","author":"AM Ben","year":"2006","unstructured":"Ben AM. Cannabinoids in medicine: a review of their therapeutic potential. J Ethnopharmacol. 2006;105(1\u20132):1\u201325. https:\/\/doi.org\/10.1016\/j.jep.2006.02.001.","journal-title":"J Ethnopharmacol"},{"key":"447_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2803-2","author":"N Montero-Oleas","year":"2020","unstructured":"Montero-Oleas N, Arevalo-Rodriguez I, Nu\u00f1ez-Gonz\u00e1lez S, et al. Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews. BMC Complement Med Ther. 2020. https:\/\/doi.org\/10.1186\/s12906-019-2803-2.","journal-title":"BMC Complement Med Ther."},{"key":"447_CR4","unstructured":"Government of Canada. Marihuana Medical Access Regulations (SOR\/2001-227) [Internet]. Canada Gaz. 2001 p. 1\u201330."},{"issue":"1","key":"447_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000505028","volume":"3","author":"AK Schlag","year":"2020","unstructured":"Schlag AK. An evaluation of regulatory regimes of medical cannabis: what lessons can be learned for the UK? Med Cannabis Cannabinoids. 2020;3(1):25\u201360. https:\/\/doi.org\/10.1159\/000505028.","journal-title":"Med Cannabis Cannabinoids."},{"key":"447_CR6","unstructured":"Ipsos. New global study: most believe that cannabis will be legal in coming years | Ipsos [Internet]. Glob. Views Vices \u2013 2019. 2019."},{"key":"447_CR7","unstructured":"Gallup. Support for Legal Marijuana Holds at Record High of 68% [Internet]. 2021."},{"issue":"2","key":"447_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1089\/can.2019.0051","volume":"5","author":"L Kaplan","year":"2020","unstructured":"Kaplan L, Klein T, Wilson M, et al. Knowledge, practices, and attitudes of Washington State health care professionals regarding medical cannabis. Cannabis Cannabinoid Res. 2020;5(2):172\u201382. https:\/\/doi.org\/10.1089\/can.2019.0051.","journal-title":"Cannabis Cannabinoid Res."},{"issue":"1","key":"447_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s42238-021-00100-1","volume":"3","author":"JM Weisman","year":"2021","unstructured":"Weisman JM, Rodr\u00edguez M. A systematic review of medical students\u2019 and professionals\u2019 attitudes and knowledge regarding medical cannabis. J Cannabis Res. 2021;3(1):47. https:\/\/doi.org\/10.1186\/s42238-021-00100-1.","journal-title":"J Cannabis Res."},{"key":"447_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-021-01559-w","author":"ST R\u00f8nne","year":"2021","unstructured":"R\u00f8nne ST, Rosenb\u00e6k F, Pedersen LB, et al. Physicians\u2019 experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review. BMC Fam Pract. 2021. https:\/\/doi.org\/10.1186\/s12875-021-01559-w.","journal-title":"BMC Fam Pract"},{"key":"447_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0216556","author":"KM Gardiner","year":"2019","unstructured":"Gardiner KM, Singleton JA, Sheridan J, et al. Health professional beliefs, knowledge, and concerns surrounding medicinal cannabis\u2014a systematic review. PLoS ONE. 2019. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0216556.","journal-title":"PLoS ONE"},{"key":"447_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00083-z","author":"JM Orjuela-Rojas","year":"2021","unstructured":"Orjuela-Rojas JM, Garc\u00eda Orjuela X, Ocampo SS. Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists. J Cannabis Res. 2021. https:\/\/doi.org\/10.1186\/s42238-021-00083-z.","journal-title":"J Cannabis Res."},{"key":"447_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-016-0129-7","author":"D Crowley","year":"2017","unstructured":"Crowley D, Collins C, Delargy I, et al. Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey. Harm Reduct J. 2017. https:\/\/doi.org\/10.1186\/s12954-016-0129-7.","journal-title":"Harm Reduct J"},{"issue":"19","key":"447_CR14","doi-asserted-by":"publisher","first-page":"4545","DOI":"10.3390\/jcm10194545","volume":"10","author":"M Hordowicz","year":"2021","unstructured":"Hordowicz M, Jarosz J, Czapli\u0144ska M, et al. Polish physicians\u2019 perspectives on medical cannabis policy and educational needs: results of an online survey. J Clin Med. 2021;10(19):4545. https:\/\/doi.org\/10.3390\/jcm10194545.","journal-title":"J Clin Med"},{"issue":"2","key":"447_CR15","first-page":"e78","volume":"64","author":"GM Allan","year":"2018","unstructured":"Allan GM, Finley CR, Ton J, et al. Systematic review of systematic reviews for medical cannabinoids. Can Fam Physician. 2018;64(2):e78-94.","journal-title":"Can Fam Physician"},{"key":"447_CR16","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s40263-021-00879-w","volume":"1","author":"F Petzke","year":"2022","unstructured":"Petzke F, T\u00f6lle T, Fitzcharles MA, et al. Cannabis-based medicines and medical cannabis for chronic neuropathic Pain. CNS Drugs Adis. 2022;1:31\u201344.","journal-title":"CNS Drugs. Adis"},{"key":"447_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1179544120906461","author":"H Johal","year":"2020","unstructured":"Johal H, Devji T, Chang Y, et al. Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord. 2020. https:\/\/doi.org\/10.1177\/1179544120906461.","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord."},{"key":"447_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n1034","author":"L Wang","year":"2021","unstructured":"Wang L, Hong PJ, May C, et al. Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials. BMJ. 2021. https:\/\/doi.org\/10.1136\/bmj.n1034.","journal-title":"BMJ"},{"issue":"24","key":"447_CR19","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1001\/jama.2015.6358","volume":"313","author":"PF Whiting","year":"2015","unstructured":"Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA J Am Med Assoc. 2015;313(24):2456\u201373. https:\/\/doi.org\/10.1001\/jama.2015.6358.","journal-title":"JAMA J Am Med Assoc"},{"issue":"12","key":"447_CR20","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","volume":"6","author":"N Black","year":"2019","unstructured":"Black N, Stockings E, Campbell G, et al. Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(12):995\u20131010. https:\/\/doi.org\/10.1016\/S2215-0366(19)30401-8.","journal-title":"Lancet Psychiatry"},{"key":"447_CR21","volume-title":"The health effects of cannabis and cannabinoids [Internet]","author":"National Academies of Sciences Engineering and Medicine","year":"2017","unstructured":"National Academies of Sciences Engineering and Medicine. The health effects of cannabis and cannabinoids [Internet]. Washington, D.C.: National Academies Press; 2017. (10.17226\/24625)."},{"key":"447_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090525","author":"L Orsolini","year":"2019","unstructured":"Orsolini L, Chiappini S, Volpe U, et al. Use of medicinal cannabis and synthetic cannabinoids in post-traumatic stress disorder (PTSD): a systematic review. Med Medicina (Kaunas). 2019. https:\/\/doi.org\/10.3390\/medicina55090525.","journal-title":"Med Medicina (Kaunas)."},{"key":"447_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012182.pub2","author":"M M\u00fccke","year":"2018","unstructured":"M\u00fccke M, Phillips T, Radbruch L, et al. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2018. https:\/\/doi.org\/10.1002\/14651858.CD012182.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"447_CR24","doi-asserted-by":"publisher","DOI":"10.19191\/EP17.5-6.AD01.069","author":"L Amato","year":"2017","unstructured":"Amato L, Minozzi S, Mitrova Z, et al. Revisione sistematica sull\u2019efficacia terapeutica e la sicurezza della cannabis per i pazienti affetti da sclerosi multipla, dolore neuropatico cronico e pazienti oncologici che assumono chemioterapie. Epidemiol Prev. 2017. https:\/\/doi.org\/10.19191\/EP17.5-6.AD01.069.","journal-title":"Epidemiol Prev"},{"issue":"4","key":"447_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.9758\/cpn.2017.15.4.301","volume":"15","author":"K Lim","year":"2017","unstructured":"Lim K, See YM, Lee J. A systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders. Clin Psychopharmacol Neurosci. 2017;15(4):301\u201312. https:\/\/doi.org\/10.9758\/cpn.2017.15.4.301.","journal-title":"Clin Psychopharmacol Neurosci."},{"key":"447_CR26","volume-title":"International Classification of Diseases, 11th Revision (ICD-11)","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Geneva [Internet]: World Heal. Organ; 2018."},{"key":"447_CR27","unstructured":"ANZCTR. ANZCTR Data field definitions [Internet]. 2019. p. 1\u201326."},{"key":"447_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/432607","author":"AH Sam","year":"2011","unstructured":"Sam AH, Salem V, Ghatei MA. Rimonabant: from RIO to Ban. J Obes. 2011. https:\/\/doi.org\/10.1155\/2011\/432607.","journal-title":"J Obes"},{"key":"447_CR29","unstructured":"European Medicines Agency T. PRESS RELEASE The European Medicines Agency recommends suspension of the marketing authorisation of Acomplia [Internet]. 2008. p. 4\u20135."},{"key":"447_CR30","unstructured":"International Association for Cannabis as Medicine. Recommendation of suspension of the marketing authorisation of rimonabant and discontinuation of clinical research into cannabinoid receptor antagonists [Internet]. 2008."},{"issue":"58","key":"447_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/jncimonographs\/lgab009","volume":"2021","author":"ZD Cooper","year":"2021","unstructured":"Cooper ZD, Abrams DI, Gust S, et al. Challenges for clinical cannabis and cannabinoid research in the United States. J Natl Cancer Inst Monogr. 2021;2021(58):114\u201322. https:\/\/doi.org\/10.1093\/jncimonographs\/lgab009.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"447_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.777804","author":"KB Walsh","year":"2021","unstructured":"Walsh KB, McKinney AE, Holmes AE. Minor cannabinoids: biosynthesis, molecular pharmacology and potential therapeutic uses. Front Pharmacol. 2021. https:\/\/doi.org\/10.3389\/fphar.2021.777804.","journal-title":"Front Pharmacol"},{"key":"447_CR33","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1691428","author":"F Pellati","year":"2018","unstructured":"Pellati F, Borgonetti V, Brighenti V, et al. Cannabis sativa L. and nonpsychoactive cannabinoids: their chemistry and role against oxidative stress, inflammation, and cancer. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/1691428.","journal-title":"Biomed Res Int"},{"key":"447_CR34","unstructured":"National Center for Drug Abuse Statistics. Opioids crisis statistics: prescription opioid abuse. [Internet]. 2022."},{"issue":"10","key":"447_CR35","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/j.1360-0443.2010.03052.x","volume":"105","author":"JA Boscarino","year":"2010","unstructured":"Boscarino JA, Rukstalis M, Hoffman SN, et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US healthcare system. Addiction. 2010;105(10):1776\u201382. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03052.x.","journal-title":"Addiction"},{"key":"447_CR36","unstructured":"National Institutes of Health (NIH). NIH to investigate minor cannabinoids and terpenes for potential pain-relieving properties [Internet]. ENP Newswire. 2019."},{"key":"447_CR37","doi-asserted-by":"crossref","unstructured":"Zhong H, Chan G, Hu Y, et al. A comprehensive map of FDA-approved pharmaceutical products. Pharmaceutics. 2018;10(4):263.","DOI":"10.3390\/pharmaceutics10040263"},{"issue":"3","key":"447_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/BLUTZ","volume":"22","author":"B Lutz","year":"2020","unstructured":"Lutz B. Neurobiology of cannabinoid receptor signaling. Dialogues Clin Neurosci. 2020;22(3):207\u201322. https:\/\/doi.org\/10.31887\/DCNS.2020.22.3\/BLUTZ.","journal-title":"Dialogues Clin Neurosci"},{"key":"447_CR39","doi-asserted-by":"publisher","unstructured":"Drug Enforcement Administration. Drug Scheduling [Internet]. 2006. p. 299\u2013309. https:\/\/doi.org\/10.1201\/9781420009835.ax1","DOI":"10.1201\/9781420009835.ax1"},{"key":"447_CR40","unstructured":"Therapeutic Goods Administration. Medicinal cannabis: Role of the TGA | Therapeutic Goods Administration (TGA) [Internet]. Ther. Goods Adm. 2021."},{"key":"447_CR41","doi-asserted-by":"publisher","first-page":"102336","DOI":"10.1016\/j.ctim.2020.102336","volume":"49","author":"S Goyal","year":"2020","unstructured":"Goyal S, Kubendran S, Kogan M, et al. High expectations: The landscape of clinical trials of medical marijuana in oncology. Complement Ther Med. 2020;49:102336.","journal-title":"Complement Ther Med"},{"key":"447_CR42","unstructured":"Kowal MA, Hazekamp A, Grotenhermen F. Review on clinical studies with cannabis and cannabinoids 2010\u20132014. Cannabinoids. 2016;11:1\u201318."},{"key":"447_CR43","unstructured":"ClinicalTrials.gov. Disclaimer [Internet]."},{"key":"447_CR44","unstructured":"EU Clinical Trials Register. About the Clinical Trials Register-Legal Notice [Internet]."},{"key":"447_CR45","unstructured":"Australian New Zealand Clinical Trials Registry (ANZCTR). Disclaimer [Internet]. Aust. New Zeal. Clin. Trials Regist. 2021."},{"issue":"19","key":"447_CR46","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1001\/jama.297.19.2112","volume":"297","author":"DA Zarin","year":"2007","unstructured":"Zarin DA, Ide NC, Tse T, et al. Issues in the registration of clinical trials. J Am Med Assoc. 2007;297(19):2112\u201320. https:\/\/doi.org\/10.1001\/jama.297.19.2112.","journal-title":"J Am Med Assoc"},{"issue":"5","key":"447_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1056\/nejmoa0707427","volume":"358","author":"U Wilbert-Lampen","year":"2008","unstructured":"Wilbert-Lampen U, Leistner D, Greven S, et al. Cardiovascular events during world cup soccer. N Engl J Med. 2008;358(5):475\u201383. https:\/\/doi.org\/10.1056\/nejmoa0707427.","journal-title":"N Engl J Med"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-022-00447-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00447-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T17:30:56Z","timestamp":1669483856000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-022-00447-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["447"],"URL":"https:\/\/doi.org\/10.1007\/s40290-022-00447-7","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"assertion":[{"value":"21 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No grant or financial contribution was received from a third party.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"FM and KT declare that this study was conducted without any commercial or financial relationships that could be considered a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"FM: Conceptualization, methodology, investigation, data curation, writing\u2014original draft, review and editing, visualization. KT: Conceptualization, methodology, investigation, data curation, writing\u2014review and editing, visualization. All authors approved the final version of this manuscript to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}},{"value":"Data supporting this study are openly available from the website of respective clinical trial registries:\n                      \n                      ,\n                      \n                      ,\n                      \n                      ,\n                      \n                      .","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Access Statement"}},{"value":"There is no human subject or identifiable personal information in this article, and informed consent is not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}